Table 1.
Demographic Characteristics & Recruitment Subgroups (N=99)
| Recruitment Subgroups | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total Sample n (%)/M (SD) | Detoxification Unit (n=63) n (%)/M (SD) | Sexual Health Clinics (n=36) n (%)/M (SD) | F/ χ2 | Pa | ||||
| Gender Identity | N/A | .004b | ||||||
| Cisgender Men | 85 (85.9) | 50 (79.4) | 35 (97.2) | |||||
| Cisgender Women | 12 (12.1) | 12 (19.1) | 0 (0.0) | |||||
| Transgender Women | 2 (2.0) | 1 (1.6) | 1 (2.8) | |||||
| Race & Ethnicity | N/A | .001b | ||||||
| Black/African American, Non-Hispanic | 51 (50.5) | 40 (63.5) | 11 (30.6) | |||||
| Hispanic/Latinx, Any Race | 35 (35.4) | 20 (31.8) | 15 (41.7) | |||||
| White, Non-Hispanic | 12 (12.1) | 3 (4.8) | 9 (25.00) | |||||
| Other/Multiracial, Non-Hispanic | 1 (1.0) | 0 (0.0) | 1 (2.8) | |||||
| Substance Use Disorders | ||||||||
| Alcohol Use Disorder | 56 (56.6) | 37 (58.7) | 19 (52.8) | .330 | .565 | |||
| Cannabis Use Disorder | 34 (34.3) | 19 (30.2) | 15 (41.7) | 1.35 | .246 | |||
| Opioid Use Disorder | 26 (26.6) | 25 (39.7) | 1 (2.8) | 16.11 | <.001 | |||
| Stimulant Use Disorder | 60 (60.6) | 47 (74.6) | 13 (36.1) | 14.23 | <.001 | |||
| HIV Diagnosis | N/A | <.001b | ||||||
| ≥ 2012 | 36 (36.4) | 3 (4.8) | 33 (91.7) | |||||
| < 2012 | 63 (63.6) | 60 (95.2) | 3 (8.3) | |||||
| HIV Outcomes | ||||||||
| Linked to Care | 89 (89.9) | 63 (100.0) | 26 (72.2) | N/A | <.001b | |||
| Initiated Antiretroviral Therapy | 76 (76.8) | 59 (93.7) | 17 (47.2) | 27.69 | <.001 | |||
| Virally suppressed at 6-month follow-up | 62 (62.62) | 33 (52.4) | 29 (80.6) | 6.06 | .014 | |||
| Age | 43.6 (13.2) | 52.5 (6.0) | 28.1 (6.0) | .175 | <.001 | |||
| Years of Education | 13.1 (2.5) | 12.1 (2.1) | 14.9 (2.0) | .214 | <.001 | |||
a
Bold indicates P-values < .05
b
P-values are based on Fisher’s Exact Tests